Target intelligence / Profile preview

Airway mucus gel layer

Molecular classification
Other, Mucin-based hydrogel, Complex biological matrix
01

Overview

The airway mucus gel layer is a critical viscoelastic barrier lining the respiratory epithelium, primarily composed of water, ions, and large gel-forming mucins such as MUC5AC and MUC5B (Fahy & Dickey, 2010, NEJM). Its primary biological function is to trap inhaled particulates, allergens, and pathogens, facilitating their removal from the lungs via the mucociliary escalator (Boucher, 2019, NIH). In pathological states like cystic fibrosis, COPD, and asthma, the mucus layer becomes abnormally thick, dehydrated, and adhesive, leading to airway obstruction, impaired clearance, and a niche for chronic bacterial colonization (Button et al., 2012, Science). Pharmacological intervention focuses on modifying the physical properties of this gel—such as its rheology and hydration—to restore effective clearance and reduce the burden of obstructive lung disease. Common therapeutic strategies include the use of mucolytics to break down the mucin network and osmotic agents to draw water into the gel layer (Widdicombe, 2002, J Physiol). Understanding the structural integrity and clearance dynamics of this layer is essential for developing treatments that alleviate the symptoms of chronic respiratory conditions.

Other names
Airway mucusTracheobronchial mucusBronchial mucusAirway surface liquid gel layer
02

Mechanism of action

Reduction of mucus viscosity via disulfide bond disruption (classic mucolytics), degradation of extracellular DNA (nucleolytics), and enhancement of gel hydration through osmotic gradients (osmotic agents) to facilitate clearance by coughing or ciliary action.

03

Biological functions

Immune responseMucociliary clearancePhysical barrier protectionPathogen trappingAirway hydrationLubrication
04

Disease associations

InfectionInflammationCystic fibrosisChronic obstructive pulmonary disease (COPD)AsthmaBronchiectasis
05

Safety considerations

Drug-induced bronchospasmAirway irritationCough inductionPotential for excessive thinning leading to impaired barrier functionAspiration risk in patients with impaired cough reflex
06

Interacting drugs

N-acetylcysteine

6 more in the full profile.

07

Biomarkers

Mucus viscosityMUC5AC concentrationMUC5B concentrationSputum volumeMucociliary clearance rate (MCC)

Beyond the preview

Go deeper on Airway mucus gel layer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Airway mucus gel layer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call